Bagundol, Gloria C.
HRN: 22-80-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFUROXIME 500MG (TAB)
01/28/2025
02/03/2025
P0
500mg
BID
S/P ENDOMETRIAL CURRETAGE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes